secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2026-09-25T11:59:19+00:00
Accession:  0001398733-26-000048
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Aquestive furnishes Sept 23, 2026 investor presentation; 8-K text contains no operational or financial detail
--------------------------------------------------------------------------------

- Exhibit 99.1 is titled 'Corporate Presentation' dated September 23, 2026; the appended exhibit text contains only the standard forward-looking-statement disclaimer.
- No revenue, EPS, guidance, clinical-trial or partnership data appears anywhere in the filing or the exhibit text provided.
- Event date listed as September 23, 2026; the 8-K is dated and signed September 25, 2026 by CFO A. Ernest Toth, Jr.
- Company says the deck is available on the Events and Presentations page of the Investors section at www.aquestive.com; content was not reproduced in the filing.
- Cannot summarize substantive news because Exhibit 99.1's body was not included beyond the disclaimer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000048/0001398733-26-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000048/aqst-20260923.htm
  HTML page:      https://secwatch.observer/filing/0001398733-26-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer